Ying-Hsia Shih
Overview
Explore the profile of Ying-Hsia Shih including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
181
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chang M, Peng C, Chen C, Shih Y, Chen J, Tai Y, et al.
Pharmaceuticals (Basel)
. 2025 Jan;
17(12.
PMID: 39770405
Iodine-123 metaiodobenzylguanidine (I-123 MIBG) is a crucial radiopharmaceutical widely used in nuclear medicine for its diagnostic capabilities in both cardiology and oncology. This review aims to present a comprehensive evaluation...
2.
Shih Y, Peng C, Chiang P, Shieh M
Pharmaceutics
. 2022 Apr;
14(4).
PMID: 35456602
The aim of this research was to evaluate the receptor tyrosine kinase inhibitor Sunitinib combined with SN-38 in polymeric micelles for antitumor efficacy in colorectal cancer. First, SN-38 and Sunitinib...
3.
Peng C, Shih Y, Chiang P, Chen C, Chang M
Int J Mol Sci
. 2021 Nov;
22(22).
PMID: 34830094
Cancer is one of the leading causes of death in the world. A cancer-targeted multifunctional probe labeled with the radionuclide has been developed to provide multi-modalities for NIR fluorescence and...
4.
Guan S, Wu C, Liao T, Lin K, Peng C, Shih Y, et al.
Eur J Pharm Biopharm
. 2021 Aug;
168:38-52.
PMID: 34450241
Tumor hypoxia is a common feature in colorectal cancer (CRC), and is associated with resistance to radiotherapy and chemotherapy. Thus, a specifically targeted probe for the detection of hypoxic CRC...
5.
Chiang P, Peng C, Shih Y, Cho Y, Yu C, Kuo Y, et al.
ACS Biomater Sci Eng
. 2021 Jan;
4(9):3425-3433.
PMID: 33435076
To improve the effectiveness of cancer treatment, this study aimed to develop biodegradable microspheres and to combine chemotherapy and radiotherapy via transcatheter arterial embolization/chemoembolization (TAE/TACE) with local radiation therapy for...
6.
Shih Y, Peng C, Weng M, Chiang P, Luo T, Lin X
Mol Pharm
. 2019 Jan;
16(3):1083-1091.
PMID: 30638389
Hepatocellular carcinoma (HCC) is one of the leading causes of mortality worldwide. The aim of the present study was to evaluate the distribution and the therapeutic effect of Re-Tin-colloid micro-particles...
7.
Peng C, Lin H, Chiang W, Shih Y, Chiang P, Luo T, et al.
Photodiagnosis Photodyn Ther
. 2018 Jun;
23:111-118.
PMID: 29894822
Photodynamic therapy (PDT) is a treatment utilizing the combined action of photosensitizers and light for the treatment of various cancers. The mechanisms for tumor destruction after PDT include direct tumor...
8.
Chu W, Tsai M, Peng C, Shih Y, Luo T, Yang S, et al.
Mol Pharm
. 2018 Mar;
15(4):1432-1444.
PMID: 29498860
Photodynamic therapy (PDT) has been shown to kill cancer cells and improve survival and quality of life in cancer patients, and numerous new approaches have been considered for maximizing the...
9.
Shih Y, Luo T, Chiang P, Yao C, Lin W, Peng C, et al.
J Control Release
. 2017 Apr;
258:196-207.
PMID: 28445743
The purpose of this research was to investigate the effectiveness of epidermal growth factor receptor (EGFR) targeted micelles loaded with IR-780 (Cetuximab/IR-780/micelles) for generating tumor targeting, multimodal images, and photothermal...
10.
Ning S, Lee S, Wei M, Peng C, Lin S, Tsai M, et al.
ACS Appl Mater Interfaces
. 2016 Jun;
8(28):17793-804.
PMID: 27348241
Cancer stem-like cells play a key role in tumor development, and these cells are relevant to the failure of conventional chemotherapy. To achieve favorable therapy for colorectal cancer, PEG-PCL-based nanoparticles,...